In this issue:
Spesolimab for generalised pustular psoriasis
Drug survival of methotrexate in psoriasis
Immunomodulators and seroconversion after COVID-19 vaccination
Depression, anxiety and severe mental illness in atopic eczema and psoriasis
Palmoplantar pustulosis and plaque psoriasis disease burden
Periodontal disease and risk of subsequent psoriasis
Probiotics as an adjunctive therapy in psoriasis
Long-term psoriasis control with guselkumab, adalimumab, secukinumab, or ixekizumab
Systemic treatment of moderate-to- severe psoriasis in paediatric patients
Patient preferences in topical psoriasis treatment
Please login below to download this issue (PDF)